Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort
June 7th, 2021
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Adds First Summer Camp for safeCircle™ COVID-19 Testing
June 1st, 2021
APDN Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel
May 26th, 2021
FQ2’21 Financial Results Feature 384% Year-Over-Year Growth in Revenues
May 13th, 2021
APDN: Clarification on Newly Authorized Asymptomatic Serial Screening
May 13th, 2021
FDA Grants EUA to Applied DNA Linea™ COVID-19 Assay Kit
May 12th, 2021
APDN Receives CLIA Certification, Enabling High Throughput COVID-19 Testing
May 11th, 2021
APDN Schedules FY’21 Q2 Financial Results Conference Call/Webcast
May 7th, 2021
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6th, 2021
